Antiretroviral therapy in resource-poor settings - Decreasing barriers to access and promoting adherence

被引:106
作者
Mukherjee, Joia S.
Ivers, Louise
Leandre, Fernet
Farmer, Paul
Behforouz, Heidi
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA
[2] Zanmi Lasante, Cange, Haiti
关键词
adherence; antiretroviral therapy; community health workers; nutrition; resource-poor settings; user fees;
D O I
10.1097/01.qai.0000248348.25630.74
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Since 2002, the HIV Equity Initiative of the non-governmental organization Partners in Health has been expanded in conjunction with the Haitian MOH to cover 7 public clinics. More than 8000 HIV-positive persons, 2300 of whom are on antiretroviral therapy (ART) are now followed. This article describes the interventions to promote access to care and adherence to ART developed in reference to the specific context of poverty in rural Haiti. User fees for clinic attendance have been waived for all patients with HIV and tuberculosis and for women presenting for prenatal services. Additionally, HIV testing has been integrated into the provision of primary care services to increase HIV case finding among those presenting to clinic because of illness, rather than solely focusing on those who present for voluntary counseling and testing (VCT). Once a patient is diagnosed with HIV, medications and monitoring tests are provided free of charge and transportation costs for follow-up appointments are covered to defray patients' out-of-pocket expenses. Patients are given home-based adherence support from a network of health workers who provide psychosocial support and directly observed therapy. In addition, the neediest patients receive nutritional support. Following the description of the program is an approximation of the costs of these interventions and a discussion of their impact.
引用
收藏
页码:S123 / S126
页数:4
相关论文
共 23 条
[1]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[2]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[3]  
*CDC, 2004, MMWR-MORBID MORTAL W, V53, P1083
[4]  
de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014
[5]   Community-based approaches to HIV treatment in resource-poor settings [J].
Farmer, P ;
Léandre, F ;
Mukherjee, JS ;
Claude, MS ;
Nevil, P ;
Smith-Fawzi, MC ;
Koenig, SP ;
Castro, A ;
Becerra, MC ;
Sachs, J ;
Attaran, A ;
Kim, JY .
LANCET, 2001, 358 (9279) :404-409
[6]  
Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145
[7]   Factors associated with forced sex among women accessing health services in rural Haiti:: implications for the prevention of HIV infection and other sexually transmitted diseases [J].
Fawzi, MCS ;
Lambert, W ;
Singler, JM ;
Tanagho, Y ;
Léandre, F ;
Nevil, P ;
Bertrand, D ;
Claude, MS ;
Bertrand, J ;
Louissaint, M ;
Jeannis, L ;
Mukherjee, JS ;
Goldie, S ;
Salazar, JJ ;
Farmer, PE .
SOCIAL SCIENCE & MEDICINE, 2005, 60 (04) :679-689
[8]   A randomized trial of multivitamin supplements and HIV disease progression and mortality [J].
Fawzi, WW ;
Msamanga, GI ;
Spiegelman, D ;
Wei, RL ;
Kapiga, S ;
Villamor, E ;
Mwakagile, D ;
Mugusi, F ;
Hertzmark, E ;
Essex, M ;
Hunter, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) :23-32
[9]   Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy [J].
Frater, AJ ;
Dunn, DT ;
Beardall, AJ ;
Ariyoshi, K ;
Clarke, JR ;
McClure, MO ;
Weber, JN .
AIDS, 2002, 16 (08) :1139-1146
[10]   Effect of adherence to newly initiated antiretroviral therapy on plasma viral load [J].
Gross, R ;
Bilker, WB ;
Friedman, HM ;
Strom, BL .
AIDS, 2001, 15 (16) :2109-2117